[Antineoplastic protocols: between effectiveness and adverse effects].
Lucchi
E
E
Molitor
J L
JL
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology
Protocoles anticancéreux: entre efficacité et effets indesirables.